Los Angeles Capital Management
ANRO icon

Los Angeles Capital Management’s Alto Neuroscience ANRO Stock Holding History

Los Angeles Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5K Buy
+1,006
New +$23.3K ﹤0.01% 1710

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Los Angeles Capital Management's ANRO Position: Q2 2026 in Review

Los Angeles Capital Management opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 1,006 shares worth $26.5K. The stake represents ﹤0.01% of the portfolio and ranks #1710 among its holdings.

114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Los Angeles Capital Management held 1,006 shares of Alto Neuroscience worth $26.5K as of Q2 2026.
  • Alto Neuroscience was a new Los Angeles Capital Management position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1710 holding.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.